Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemzar + Cisplatin in Inoperable Biliary Tract Carcinoma
NCT00490399Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in biliary tract carcinoma (BTC), sponsored by Eli Lilly and Company. Started Mar 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
biliary tract carcinoma (BTC)
Beyond the preview
Go deeper on NCT00490399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490399.